Oftalmolosa Cusí Aureomicina (Chlortetracycline Hydrochloride)

Chlortetracycline Hydrochloride, the active ingredient in Oftalmolosa Cusí Aureomicina, is a tetracycline antibiotic presented as a topical ophthalmic solution for ocular use. It treats bacterial eye infections such as conjunctivitis and keratitis in patients requiring local antimicrobial therapy.

GNH USA supplies Oftalmolosa Cusí Aureomicina as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Oftalmolosa Cusí Aureomicina, a tetracycline antibiotic, is indicated for bacterial infections of the eye surface and related structures. - Bacterial conjunctivitis: reduces microbial load and accelerates symptom relief. - Keratitis: helps eradicate the causative bacteria and supports corneal healing. - Blepharitis: controls bacterial overgrowth on the eyelid margins. - Post‑surgical prophylaxis: lowers the risk of infection after ocular procedures.

Adverse reactions to topical chlortetracycline are generally mild and related to local ocular tolerance.

Common Side Effects: - Eye irritation: transient burning or stinging sensation. - Redness: mild conjunctival hyperemia. - Pruritus: itching around the application site. - Tearing: increased lacrimation. - Foreign‑body sensation: feeling of grit in the eye.

Serious or Rare Side Effects: - Allergic contact dermatitis: swelling, rash or hives around the eye. - Severe ocular inflammation: marked pain, photophobia or vision changes. - Stevens‑Johnson syndrome: extensive mucocutaneous lesions (rare).

When using Oftalmolosa Cusí Aureomicina, consider the following precautions: - Contraindication: avoid in patients with known hypersensitivity to tetracyclines. - Pregnancy: use only if clearly needed; limited data suggest caution. - Breastfeeding: potential secretion in milk; weigh benefits against risks. - Pediatric use: safety not established in children under 8 years for systemic exposure, but topical use follows local guidelines. - Contact lens wearers: remove lenses before application and re‑insert after the recommended interval. - Store at ambient temperature: keep in original container, protect from light and moisture.

Chlortetracycline may interact with other ophthalmic agents and systemic medications.

Major Interactions (Avoid): - Concurrent use with other tetracycline antibiotics: may increase local toxicity. - Combination with ophthalmic corticosteroids: can mask infection signs.

Moderate Interactions (Monitor Closely): - Antacids or iron supplements (systemic): may reduce oral absorption if taken concurrently. - Fluoroquinolone eye drops: potential additive irritation. - Systemic doxycycline: overlapping tetracycline class effects. - Preservative‑containing drops: may increase ocular surface irritation.